Financial Ratios Stemtech Corporation

Stocks

STEK

US85859W1027

Pharmaceuticals

Market Closed - OTC Markets 11:27:32 2026-08-28 EDT			5-day change	1st Jan Change
0.000100 ^USD	0.00%		0.00%	-87.50%

08-14	Stemtech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-22	Stemtech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

16b16aa66ad7c0782b6f0cf73.mMqVC-vyPoAfzk8ekiZcE50fYGnjHLTXLpJEY10IFvM.1bDdRoCBTcssviBrw2FpR69bDQaUeMeSf_UgMGl-e72gv9BAvJRN9Ee8ew

Published financial data: STEMTECH CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	4.32M	4.56M	4.92M	5.05M	2.88M
Total Revenues	4.32M	4.56M	4.92M	5.05M	2.88M
Cost of Goods Sold, Total	1.02M	1.16M	1M	1.33M	567K
Gross Profit	3.3M	3.4M	3.92M	3.73M	2.31M
Selling General & Admin Expenses, Total	6.51M	8.42M	8.13M	6.11M	5.02M
R&D Expenses	-	-	13.8K	-	-
Other Operating Expenses, Total	6.51M	8.42M	8.14M	6.11M	5.02M
Operating Income	-3.21M	-5.02M	-4.22M	-2.39M	-2.71M
Interest Expense, Total	-8.33M	-4.1M	-4.89M	-1.58M	-1.45M
Net Interest Expenses	-8.33M	-4.1M	-4.89M	-1.58M	-1.45M
Other Non Operating Income (Expenses)	4.43M	-3.22M	1.51M	85.36K	111K
EBT, Excl. Unusual Items	-7.11M	-12.34M	-7.61M	-3.88M	-4.05M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Other Unusual Items	-	3.8M	2.18M	108K	-
EBT, Incl. Unusual Items	-7.11M	-8.54M	-5.43M	-3.77M	-4.05M
Income Tax Expense	-	95.62K	-	-	-
Earnings From Continuing Operations	-7.11M	-8.63M	-5.43M	-3.77M	-4.05M
Net Income to Company	-7.11M	-8.63M	-5.43M	-3.77M	-4.05M
Minority Interest	33.65K	87.9K	1.73K	3.14K	3.14K
Net Income - (IS)	-7.08M	-8.54M	-5.43M	-3.77M	-4.05M
Net Income to Common Incl Extra Items	-7.08M	-8.54M	-5.43M	-3.77M	-4.05M
Net Income to Common Excl. Extra Items	-7.08M	-8.54M	-5.43M	-3.77M	-4.05M
Per Share Items
Net EPS - Basic	-0.19	-0.19	-0.07	-0.03	-0.02
Basic EPS - Continuing Operations	-0.19	-0.19	-0.07	-0.03	-0.02
Basic Weighted Average Shares Outstanding	37.62M	46.01M	83.47M	119M	170M
Net EPS - Diluted	-0.19	-0.19	-0.07	-0.03	-0.02
Diluted EPS - Continuing Operations	-0.19	-0.19	-0.07	-0.03	-0.02
Diluted Weighted Average Shares Outstanding	37.62M	46.01M	83.47M	119M	170M
Normalized Basic EPS	-0.12	-0.17	-0.06	-0.02	-0.01
Normalized Diluted EPS	-0.12	-0.17	-0.06	-0.02	-0.01
Supplemental Items
EBITDA	-2.78M	-3.12M	-3.64M	-2.04M	-2.54M
EBITA	-3.21M	-3.57M	-4.22M	-2.39M	-2.71M
EBIT	-3.21M	-5.02M	-4.22M	-2.39M	-2.71M
EBITDAR	-2.68M	-3.03M	-3.56M	-	-
Effective Tax Rate - (Ratio)	-	-1.12	-	-	-
Normalized Net Income	-4.41M	-7.62M	-4.76M	-2.42M	-2.53M
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.75M	1.58M	1.69M	880K	464K
General and Administrative Expenses	4.75M	6.84M	6.44M	5.23M	4.55M
Research And Development Expense From Footnotes	-	-	13.8K	-	-
Net Rental Expense, Total	106K	85.63K	73.31K	-	-
Imputed Operating Lease Interest Expense	6.02M	2.05M	1.15M	-	-
Imputed Operating Lease Depreciation	-5.92M	-1.97M	-1.08M	-	-
Stock-Based Comp., Other (Total)	1.03M	4M	893K	1.19M	1.57M
Total Stock-Based Compensation	1.03M	4M	893K	1.19M	1.57M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	828K	132K	114K	255K	238K
Total Cash And Short Term Investments	828K	132K	114K	255K	238K
Accounts Receivable, Total	10.72K	34.77K	61.49K	270K	-
Total Receivables	10.72K	34.77K	61.49K	270K	-
Inventory	436K	158K	48.32K	197K	217K
Prepaid Expenses	325K	287K	177K	199K	1.48K
Total Current Assets	1.6M	612K	401K	922K	457K
Gross Property Plant And Equipment	441K	-	-	-	-
Accumulated Depreciation	-234K	-	-	-	-
Net Property Plant And Equipment	207K	170K	80.88K	-	-
Goodwill	467K	467K	467K	467K	467K
Other Intangibles, Total	3.41M	2.99M	2.71M	2.38M	2.21M
Other Long-Term Assets, Total	38.69K	23.06K	23.71K	16.93K	16.48K
Total Assets	5.72M	4.27M	3.68M	3.78M	3.15M
Liabilities
Accounts Payable, Total	4.05M	2.8M	2.37M	4.19M	5.36M
Accrued Expenses, Total	-	148K	72.15K	59.32K	45.79K
Short-term Borrowings	1.04M	1.13M	3.63M	4.49M	5.01M
Current Portion of Long-Term Debt	18.12K	11.25K	-	-	-
Current Portion of Leases	55.74K	119K	66.87K	-	-
Unearned Revenue Current, Total	-	39.17K	56.04K	1.46K	171K
Other Current Liabilities	4.22M	3.17M	267K	267K	-
Total Current Liabilities	9.39M	7.42M	6.46M	9.01M	10.59M
Long-Term Debt	219K	-	-	-	-
Long-Term Leases	119K	23.07K	-	-	-
Other Non Current Liabilities	-	-	-	-	267K
Total Liabilities	9.73M	7.44M	6.46M	9.01M	10.85M
Common Stock, Total	44.68K	53.44K	105K	136K	426K
Additional Paid In Capital	10.12M	19.39M	24.73M	26.36M	27.63M
Retained Earnings	-13.09M	-21.63M	-27.06M	-30.83M	-34.88M
Comprehensive Income and Other	-430K	-248K	191K	-146K	-140K
Total Common Equity	-3.36M	-2.43M	-2.04M	-4.48M	-6.96M
Minority Interest	-650K	-738K	-739K	-743K	-746K
Total Equity	-4.01M	-3.17M	-2.78M	-5.23M	-7.7M
Total Liabilities And Equity	5.72M	4.27M	3.68M	3.78M	3.15M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	44.69M	64.74M	117M	142M	2.07B
ECS Total Common Shares Outstanding	44.69M	53.44M	105M	136M	426M
Book Value / Share	-0.08	-0.05	-0.02	-0.03	-0.02
Tangible Book Value	-7.23M	-5.9M	-5.22M	-7.33M	-9.63M
Tangible Book Value Per Share	-0.16	-0.11	-0.05	-0.05	-0.02
Total Debt	1.45M	1.29M	3.7M	4.49M	5.01M
Net Debt	622K	1.15M	3.58M	4.23M	4.77M
Debt Equivalent Oper. Leases	845K	685K	586K	-	-
Minority Interest, Total (Incl. Fin. Div)	-650K	-738K	-739K	-743K	-746K
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	187K	54.76K	-	-	-
Inventories - Work In Process, Total	-	-	-	-	-
Inventories - Finished Goods, Total	250K	103K	48.32K	197K	217K
Machinery, Total	-	-	-	-	-
Full Time Employees	-	-	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-7.08M	-8.54M	-5.43M	-3.77M	-4.05M
Depreciation & Amortization - CF	429K	447K	660K	415K	167K
Amortization of Goodwill and Intangible Assets - (CF)	-	1.46M	-	-	-
Depreciation & Amortization, Total	429K	1.9M	660K	415K	167K
Amortization of Deferred Charges, Total - (CF)	603K	2.43M	2.8M	362K	56.06K
Stock-Based Compensation (CF)	1.03M	4M	893K	1.19M	1.57M
Other Operating Activities, Total	2.13M	-665K	-2.05M	-178K	-3.14K
Change In Accounts Receivable	15.1K	-24.05K	-26.73K	-208K	270K
Change In Inventories	-238K	278K	110K	-149K	-19.98K
Change In Accounts Payable	1.22M	-683K	957K	1.81M	1.16M
Change in Unearned Revenues	-	39.17K	16.87K	-54.58K	170K
Change in Other Net Operating Assets	-21.73K	53.27K	34.43K	-15.84K	198K
Cash from Operations	-1.91M	-1.22M	-2.04M	-601K	-484K
Capital Expenditure	-	-	-	-	-
Cash from Investing	-	-	-	-	-
Short Term Debt Issued, Total	-	214K	2.24M	886K	460K
Long-Term Debt Issued, Total	3.32M	611K	-	-	-
Total Debt Issued	3.32M	826K	2.24M	886K	460K
Short Term Debt Repaid, Total	-35K	-	-657K	-282K	-
Long-Term Debt Repaid, Total	-658K	-587K	-	-	-
Total Debt Repaid	-693K	-587K	-657K	-282K	-
Issuance of Common Stock	-	100K	-	475K	-
Cash from Financing	2.63M	339K	1.58M	1.08M	460K
Foreign Exchange Rate Adjustments	-19.5K	182K	438K	-337K	6.52K
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	695K	-696K	-18.32K	141K	-17.05K
Supplemental Items
Cash Interest Paid	-	36.2K	6.82K	6.82K	-
Levered Free Cash Flow	-59.6K	799K	-4.54M	861K	965K
Unlevered Free Cash Flow	4.54M	931K	-4.28M	1.49M	1.82M
Change In Net Working Capital	-5.09M	1.83M	3.2M	-1.38M	-1.78M
Net Debt Issued / Repaid	2.63M	239K	1.58M	604K	460K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-37.4	-62.87	-66.42	-39.96	-48.85
Return on Total Capital	1.01K	141.37	545.48	-1.65K	98.53
Return On Equity %	519.54	240.56	182.57	94.25	62.64
Return on Common Equity	962.01	295.17	242.78	115.57	70.73
Margin Analysis
Gross Profit Margin %	76.32	74.47	79.65	73.75	80.29
SG&A Margin	150.61	184.65	165.21	120.98	174.47
EBITDA Margin %	-64.37	-68.4	-73.89	-40.41	-88.36
EBITA Margin %	-74.29	-78.21	-85.84	-47.22	-94.18
EBIT Margin %	-74.29	-110.18	-85.84	-47.22	-94.18
Income From Continuing Operations Margin %	-164.56	-189.34	-110.37	-74.65	-140.8
Net Income Margin %	-163.78	-187.41	-110.34	-74.59	-140.69
Net Avail. For Common Margin %	-163.78	-187.41	-110.34	-74.59	-140.69
Normalized Net Income Margin	-102.07	-167.18	-96.64	-47.93	-87.89
Levered Free Cash Flow Margin	-1.38	17.52	-92.32	17.03	33.55
Unlevered Free Cash Flow Margin	105.15	20.43	-87.02	29.39	63.16
Asset Turnover
Asset Turnover	0.81	0.91	1.24	1.35	0.83
Fixed Assets Turnover	25.93	24.16	39.22	-	-
Receivables Turnover (Average Receivables)	236.51	200.47	102.25	30.51	-
Inventory Turnover (Average Inventory)	3.22	3.92	9.71	10.8	2.73
Short Term Liquidity
Current Ratio	0.17	0.08	0.06	0.1	0.04
Quick Ratio	0.09	0.02	0.03	0.06	0.02
Operating Cash Flow to Current Liabilities	-0.2	-0.16	-0.32	-0.07	-0.05
Days Sales Outstanding (Average Receivables)	1.54	1.82	3.57	11.99	-
Days Outstanding Inventory (Average Inventory)	113.27	93.2	37.6	33.9	133.49
Average Days Payable Outstanding	999.2	1.35K	1.02K	821.99	2.99K
Cash Conversion Cycle (Average Days)	-884.39	-1.25K	-981.95	-776.09	-
Long Term Solvency
Total Debt/Equity	-36.21	-40.53	-133.05	-85.89	-64.97
Total Debt / Total Capital	-56.75	-68.15	402.59	-608.61	-185.44
LT Debt/Equity	-8.45	-0.73	-	-	-
Long-Term Debt / Total Capital	-13.25	-1.22	-	-	-
Total Liabilities / Total Assets	170.02	174.34	175.44	238.19	344.61
EBIT / Interest Expense	-0.39	-1.23	-0.86	-1.51	-1.87
EBITDA / Interest Expense	-0.32	-0.74	-0.73	-1.25	-1.75
(EBITDA - Capex) / Interest Expense	-0.32	-0.74	-0.73	-1.25	-1.75
Total Debt / EBITDA	-0.54	-0.42	-1.04	-2.28	-1.97
Net Debt / EBITDA	-0.23	-0.38	-1.01	-2.15	-1.88
Total Debt / (EBITDA - Capex)	-0.54	-0.42	-1.04	-2.28	-1.97
Net Debt / (EBITDA - Capex)	-0.23	-0.38	-1.01	-2.15	-1.88
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-1.44	5.51	7.94	2.69	-43.08
Gross Profit, 1 Yr. Growth %	-10.12	2.95	15.45	-4.91	-38.04
EBITDA, 1 Yr. Growth %	177.75	12.11	16.62	-43.85	24.47
EBITA, 1 Yr. Growth %	124.21	11.08	18.47	-43.51	13.52
EBIT, 1 Yr. Growth %	124.21	56.48	-15.9	-43.51	13.52
Earnings From Cont. Operations, 1 Yr. Growth %	311.6	21.4	-37.08	-30.55	7.35
Net Income, 1 Yr. Growth %	672.06	20.73	-36.45	-30.58	7.35
Normalized Net Income, 1 Yr. Growth %	2.07K	72.81	-37.61	-49.07	4.37
Diluted EPS Before Extra, 1 Yr. Growth %	93.07	-5.2	-63.16	-54.63	-24.96
Accounts Receivable, 1 Yr. Growth %	-58.49	224.32	76.87	338.66	-
Inventory, 1 Yr. Growth %	119.71	-63.78	-69.42	308.39	10.13
Net Property, Plant and Equip., 1 Yr. Growth %	64.5	-17.93	-52.45	-	-
Total Assets, 1 Yr. Growth %	14.18	-25.4	-13.68	2.69	-16.73
Tangible Book Value, 1 Yr. Growth %	201.33	-18.45	-11.51	40.45	31.48
Common Equity, 1 Yr. Growth %	-278.09	-27.46	-16.22	119.89	55.18
Cash From Operations, 1 Yr. Growth %	617.65	-36.42	67.3	-70.47	-19.56
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-110.24	-1.44K	-668.78	-118.94	62.55
Unlevered Free Cash Flow, 1 Yr. Growth %	577.99	-79.5	-559.8	-134.68	49.1
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-19.19	1.97	6.72	5.28	-23.55
Gross Profit, 2 Yr. CAGR %	-21.79	-3.81	9.02	4.77	-23.24
EBITDA, 2 Yr. CAGR %	12.92	76.46	14.34	-19.08	-16.4
EBITA, 2 Yr. CAGR %	10.37	57.81	14.71	-18.19	-19.92
EBIT, 2 Yr. CAGR %	10.37	87.31	14.71	-31.08	-19.92
Earnings From Cont. Operations, 2 Yr. CAGR %	57.41	123.54	-12.6	-33.89	-13.65
Net Income, 2 Yr. CAGR %	59.24	205.31	-12.41	-33.58	-13.67
Normalized Net Income, 2 Yr. CAGR %	63.95	513.08	3.84	-43.63	-27.09
Diluted EPS Before Extra, 2 Yr. CAGR %	-39.55	38.95	-40.9	-59.12	-41.65
Accounts Receivable, 2 Yr. CAGR %	-60.56	16.03	139.51	178.55	-
Inventory, 2 Yr. CAGR %	14.77	-10.8	-66.72	11.74	112.07
Net Property, Plant and Equip., 2 Yr. CAGR %	-10.67	16.19	-37.53	-	-
Total Assets, 2 Yr. CAGR %	-1.04	-7.71	-19.76	-5.85	-7.53
Tangible Book Value, 2 Yr. CAGR %	75.55	56.76	-15.05	11.49	35.89
Common Equity, 2 Yr. CAGR %	19.53	13.66	-22.04	35.73	84.72
Cash From Operations, 2 Yr. CAGR %	40.69	113.6	3.14	-29.71	-51.26
Levered Free Cash Flow, 2 Yr. CAGR %	-	17.15	773.14	3.8	-53.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	17.89	-2.92	26.28	-34.87
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-11.68	3.93	5.36	-14.23
Gross Profit, 3 Yr. CAGR %	-	-14.28	2.23	4.16	-12.06
EBITDA, 3 Yr. CAGR %	-	12.65	53.7	-9.79	-6.59
EBITA, 3 Yr. CAGR %	-	10.6	43.43	-9.41	-8.75
EBIT, 3 Yr. CAGR %	-	23.99	43.43	-9.41	-18.6
Earnings From Cont. Operations, 3 Yr. CAGR %	-	44.35	46.5	-19.05	-22.3
Net Income, 3 Yr. CAGR %	-	45.2	80.94	-18.94	-22.05
Normalized Net Income, 3 Yr. CAGR %	-	66.85	186.24	-18.11	-30.78
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-28.51	-10.73	-45.89	-49.94
Accounts Receivable, 3 Yr. CAGR %	-	-20.39	33.54	193.04	-
Inventory, 3 Yr. CAGR %	-	-21.86	-37.57	-23.24	11.2
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-13.16	-13.74	-	-
Total Assets, 3 Yr. CAGR %	-	-9.94	-9.74	-12.88	-9.63
Tangible Book Value, 3 Yr. CAGR %	-	35.96	29.55	0.45	17.79
Common Equity, 3 Yr. CAGR %	-	1.2	2.67	10.15	41.92
Cash From Operations, 3 Yr. CAGR %	-	7.97	96.9	-32.02	-26.48
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	98.37	143.53	6.51
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	85.57	-31.11	24.94
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-5.25	-8.09
Gross Profit, 5 Yr. CAGR %	-	-	-	-7.12	-8.84
EBITDA, 5 Yr. CAGR %	-	-	-	-1.31	20.47
EBITA, 5 Yr. CAGR %	-	-	-	-1.97	13.6
EBIT, 5 Yr. CAGR %	-	-	-	-1.97	13.6
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	5.62	18.58
Net Income, 5 Yr. CAGR %	-	-	-	6.19	34.58
Normalized Net Income, 5 Yr. CAGR %	-	-	-	8.1	65.63
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-42.83	-24.7
Accounts Receivable, 5 Yr. CAGR %	-	-	-	31.38	-
Inventory, 5 Yr. CAGR %	-	-	-	-9.84	1.82
Total Assets, 5 Yr. CAGR %	-	-	-	-8.32	-8.86
Tangible Book Value, 5 Yr. CAGR %	-	-	-	25.58	32.05
Common Equity, 5 Yr. CAGR %	-	-	-	13.81	29.86
Cash From Operations, 5 Yr. CAGR %	-	-	-	-9.07	12.64
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	10.64
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	22.07